SynthesisScientific reports2024

Comprehensive safety evaluation of isatuximab in multiple myeloma using disproportionality analysis of FAERS and meta-analysis of randomized controlled trials.

Muhammed Favas Karimbanathottathil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.